node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
CMAS | CSH2 | ENSP00000229329 | ENSP00000376623 | cytidine monophosphate N-acetylneuraminic acid synthetase; Catalyzes the activation of N-acetylneuraminic acid (NeuNAc) to cytidine 5’-monophosphate N-acetylneuraminic acid (CMP-NeuNAc), a substrate required for the addition of sialic acid. Has some activity toward NeuNAc, N-glycolylneuraminic acid (Neu5Gc) or 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid (KDN) | chorionic somatomammotropin hormone 2 | 0.846 |
CSF2RA | CSH2 | ENSP00000394227 | ENSP00000376623 | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | chorionic somatomammotropin hormone 2 | 0.800 |
CSF2RA | JAK2 | ENSP00000394227 | ENSP00000371067 | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | Janus kinase 2; Non-receptor tyrosine kinase involved in various processes such as cell growth, development, differentiation or histone modifications. Mediates essential signaling events in both innate and adaptive immunity. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors such as growth hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR), thrombopoietin (THPO); or type II receptors including IFN-alpha, IFN-beta, IFN-gamma and multiple interleukins. Following ligand-binding to cell surface receptors, phosphorylate [...] | 0.939 |
CSH2 | CMAS | ENSP00000376623 | ENSP00000229329 | chorionic somatomammotropin hormone 2 | cytidine monophosphate N-acetylneuraminic acid synthetase; Catalyzes the activation of N-acetylneuraminic acid (NeuNAc) to cytidine 5’-monophosphate N-acetylneuraminic acid (CMP-NeuNAc), a substrate required for the addition of sialic acid. Has some activity toward NeuNAc, N-glycolylneuraminic acid (Neu5Gc) or 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid (KDN) | 0.846 |
CSH2 | CSF2RA | ENSP00000376623 | ENSP00000394227 | chorionic somatomammotropin hormone 2 | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 0.800 |
CSH2 | ENSG00000258728 | ENSP00000376623 | ENSP00000451792 | chorionic somatomammotropin hormone 2 | Uncharacterized protein | 0.800 |
CSH2 | GHR | ENSP00000376623 | ENSP00000230882 | chorionic somatomammotropin hormone 2 | growth hormone receptor; Receptor for pituitary gland growth hormone involved in regulating postnatal body growth. On ligand binding, couples to the JAK2/STAT5 pathway (By similarity) | 0.825 |
CSH2 | IFNAR2 | ENSP00000376623 | ENSP00000343957 | chorionic somatomammotropin hormone 2 | interferon (alpha, beta and omega) receptor 2; Associates with IFNAR1 to form the type I interferon receptor. Receptor for interferons alpha and beta. Involved in IFN-mediated STAT1, STAT2 and STAT3 activation. Isoform 1 and isoform 2 are directly involved in signal transduction due to their association with the TYR kinase, JAK1. Isoform 3 is a potent inhibitor of type I IFN receptor activity | 0.800 |
CSH2 | IL12RB1 | ENSP00000376623 | ENSP00000403103 | chorionic somatomammotropin hormone 2 | interleukin 12 receptor, beta 1; Functions as an interleukin receptor which binds interleukin-12 with low affinity and is involved in IL12 transduction. Associated with IL12RB2 it forms a functional, high affinity receptor for IL12. Associates also with IL23R to form the interleukin-23 receptor which functions in IL23 signal transduction probably through activation of the Jak-Stat signaling cascade | 0.800 |
CSH2 | IL20RA | ENSP00000376623 | ENSP00000314976 | chorionic somatomammotropin hormone 2 | interleukin 20 receptor, alpha; The IL20RA/IL20RB dimer is a receptor for IL19, IL20 and IL24. The IL20RA/IL10RB dimer is a receptor for IL26 | 0.800 |
CSH2 | JAK2 | ENSP00000376623 | ENSP00000371067 | chorionic somatomammotropin hormone 2 | Janus kinase 2; Non-receptor tyrosine kinase involved in various processes such as cell growth, development, differentiation or histone modifications. Mediates essential signaling events in both innate and adaptive immunity. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors such as growth hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR), thrombopoietin (THPO); or type II receptors including IFN-alpha, IFN-beta, IFN-gamma and multiple interleukins. Following ligand-binding to cell surface receptors, phosphorylate [...] | 0.801 |
CSH2 | LIFR | ENSP00000376623 | ENSP00000263409 | chorionic somatomammotropin hormone 2 | leukemia inhibitory factor receptor alpha; Signal-transducing molecule. May have a common pathway with IL6ST. The soluble form inhibits the biological activity of LIF by blocking its binding to receptors on target cells | 0.824 |
CSH2 | PRLR | ENSP00000376623 | ENSP00000371432 | chorionic somatomammotropin hormone 2 | prolactin receptor | 0.812 |
ENSG00000258728 | CSH2 | ENSP00000451792 | ENSP00000376623 | Uncharacterized protein | chorionic somatomammotropin hormone 2 | 0.800 |
ENSG00000258728 | JAK2 | ENSP00000451792 | ENSP00000371067 | Uncharacterized protein | Janus kinase 2; Non-receptor tyrosine kinase involved in various processes such as cell growth, development, differentiation or histone modifications. Mediates essential signaling events in both innate and adaptive immunity. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors such as growth hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR), thrombopoietin (THPO); or type II receptors including IFN-alpha, IFN-beta, IFN-gamma and multiple interleukins. Following ligand-binding to cell surface receptors, phosphorylate [...] | 0.800 |
GHR | CSH2 | ENSP00000230882 | ENSP00000376623 | growth hormone receptor; Receptor for pituitary gland growth hormone involved in regulating postnatal body growth. On ligand binding, couples to the JAK2/STAT5 pathway (By similarity) | chorionic somatomammotropin hormone 2 | 0.825 |
GHR | JAK2 | ENSP00000230882 | ENSP00000371067 | growth hormone receptor; Receptor for pituitary gland growth hormone involved in regulating postnatal body growth. On ligand binding, couples to the JAK2/STAT5 pathway (By similarity) | Janus kinase 2; Non-receptor tyrosine kinase involved in various processes such as cell growth, development, differentiation or histone modifications. Mediates essential signaling events in both innate and adaptive immunity. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors such as growth hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR), thrombopoietin (THPO); or type II receptors including IFN-alpha, IFN-beta, IFN-gamma and multiple interleukins. Following ligand-binding to cell surface receptors, phosphorylate [...] | 0.999 |
GHR | LIFR | ENSP00000230882 | ENSP00000263409 | growth hormone receptor; Receptor for pituitary gland growth hormone involved in regulating postnatal body growth. On ligand binding, couples to the JAK2/STAT5 pathway (By similarity) | leukemia inhibitory factor receptor alpha; Signal-transducing molecule. May have a common pathway with IL6ST. The soluble form inhibits the biological activity of LIF by blocking its binding to receptors on target cells | 0.620 |
GHR | PRLR | ENSP00000230882 | ENSP00000371432 | growth hormone receptor; Receptor for pituitary gland growth hormone involved in regulating postnatal body growth. On ligand binding, couples to the JAK2/STAT5 pathway (By similarity) | prolactin receptor | 0.926 |
IFNAR2 | CSH2 | ENSP00000343957 | ENSP00000376623 | interferon (alpha, beta and omega) receptor 2; Associates with IFNAR1 to form the type I interferon receptor. Receptor for interferons alpha and beta. Involved in IFN-mediated STAT1, STAT2 and STAT3 activation. Isoform 1 and isoform 2 are directly involved in signal transduction due to their association with the TYR kinase, JAK1. Isoform 3 is a potent inhibitor of type I IFN receptor activity | chorionic somatomammotropin hormone 2 | 0.800 |